Peak Bio, Inc.

PKBO · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$0$1$0
Short-Term Investments$0$0$0
Receivables$0$0$0
Inventory$0$0$0
Other Curr. Assets$2$2$0
Total Curr. Assets$2$3$0
Property Plant & Equip (Net)$0$4$0
Goodwill$0$0$0
Intangibles$0$0$0
Long-Term Investments$0$0$0
Tax Assets$0$0$0
Other NC Assets$0$0$0
Total NC Assets$0$4$1
Other Assets$0$0$0
Total Assets$3$8$1
Liabilities
Payables$6$4$0
Short-Term Debt$11$2$2
Tax Payable$0$0$0
Deferred Revenue$0$5-$2
Other Curr. Liab.$4$5$1
Total Curr. Liab.$21$11$3
LT Debt$0$4$0
Deferred Rev, NC$0$0$0
Deferred Tax Liab, NC$0$0$0
Other NC Liab.$0$1$0
Total NC Liab.$0$5$0
Other Liabilities$0$0$0
Cap. Leases$0$0$0
Total Liabilities$21$16$3
Equity
Pref Stock$0$0$0
Common Stock$0$0$0
Retained Earnings-$38-$25-$8
AOCI$0$0$0
Other Equity$20$17$6
Total Equity-$18-$8-$2
Supplemental Information
Minority Interest$0$0$0
Total Liab. & Tot. Equity$3$8$1
Net Debt$0$10$5$1
Peak Bio, Inc. (PKBO) Financial Statements & Key Stats | AlphaPilot